Index S&P 500
P/E 38.26
EPS (ttm) 8.75
Insider Own 6.18%
Shs Outstand 380.10M
Perf Week 1.24%
Market Cap 127.50B
Forward P/E 24.97
EPS next Y 13.40
Insider Trans -1.59%
Shs Float 357.41M
Perf Month 2.21%
Income 3.36B
PEG 3.41
EPS next Q 2.79
Inst Own 80.85%
Short Float 1.19%
Perf Quarter -4.19%
Sales 20.96B
P/S 6.08
EPS this Y 12.79%
Inst Trans 1.53%
Short Ratio 3.39
Perf Half Y 17.99%
Book/sh 50.33
P/B 6.65
EPS next Y 12.08%
ROA 8.82%
Short Interest 4.26M
Perf Year 17.85%
Cash/sh 6.32
P/C 52.97
EPS next 5Y 11.21%
ROE 18.64%
52W Range 249.98 - 361.41
Perf YTD 11.76%
Dividend Est. 3.12 (0.93%)
P/FCF 44.61
EPS past 5Y -2.45%
ROI 11.07%
52W High -7.40%
Beta 0.92
Dividend TTM 3.10 (0.93%)
Quick Ratio 0.99
Sales past 5Y 8.80%
Gross Margin 61.09%
52W Low 33.88%
ATR (14) 5.94
Dividend Ex-Date Jun 28, 2024
Current Ratio 1.71
EPS Y/Y TTM 27.45%
Oper. Margin 21.36%
RSI (14) 50.87
Volatility 1.68% 1.88%
Employees 52000
Debt/Eq 0.70
Sales Y/Y TTM 10.61%
Profit Margin 16.03%
Recom 1.87
Target Price 378.95
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q 32.45%
Payout 36.98%
Rel Volume 0.75
Prev Close 333.98
Sales Surprise 2.71%
EPS Surprise 6.13%
Sales Q/Q 9.73%
Earnings Apr 30 AMC
Avg Volume 1.26M
Price 334.68
SMA20 1.12%
SMA50 -2.32%
SMA200 8.73%
Trades
Volume 937,647
Change 0.21%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-31-24 Upgrade
Canaccord Genuity
Hold → Buy
$315 → $360
Oct-20-23 Initiated
ROTH MKM
Buy
$345
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Mar-02-22 Resumed
BofA Securities
Buy
$300
Jan-07-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$305
Jan-04-22 Upgrade
Piper Sandler
Neutral → Overweight
$250 → $315
Dec-10-21 Initiated
RBC Capital Mkts
Sector Perform
$278
Dec-07-21 Initiated
Loop Capital
Buy
$305
Show Previous Ratings
May-16-24 04:21PM
May-09-24 08:00AM
07:58AM
May-07-24 02:10AM
May-02-24 01:02AM
04:12PM
Loading…
May-01-24 04:12PM
(Investor's Business Daily)
11:53AM
11:32AM
09:55AM
09:55AM
09:54AM
09:54AM
09:51AM
09:44AM
09:39AM
09:36AM
Loading…
09:36AM
09:13AM
08:27AM
08:26AM
07:55AM
07:25AM
(Thomson Reuters StreetEvents)
06:08AM
03:27AM
Apr-30-24 08:57PM
06:11PM
06:00PM
05:32PM
05:25PM
04:55PM
(Investor's Business Daily)
04:43PM
04:25PM
Loading…
04:25PM
(Associated Press Finance)
04:16PM
(Investor's Business Daily)
04:05PM
Apr-25-24 09:15AM
Apr-24-24 08:23AM
07:50AM
06:25AM
Apr-23-24 01:38PM
10:00AM
Apr-22-24 06:08PM
Apr-21-24 08:30AM
Apr-18-24 09:35AM
Apr-05-24 04:42PM
Apr-01-24 04:05PM
Mar-29-24 09:40AM
Mar-27-24 10:54AM
Mar-26-24 04:05PM
08:02AM
03:10AM
Mar-22-24 10:39AM
Mar-21-24 11:39AM
10:00AM
07:15AM
Mar-19-24 02:23PM
Mar-07-24 04:23PM
Mar-06-24 08:46AM
Feb-29-24 10:31AM
12:04AM
Feb-28-24 02:10AM
Feb-22-24 05:25AM
Feb-18-24 01:26PM
Feb-15-24 12:07AM
Feb-13-24 02:41PM
08:00AM
05:06AM
Feb-07-24 08:00AM
Feb-05-24 08:00AM
Feb-01-24 03:03PM
(Investor's Business Daily)
10:08AM
Jan-31-24 07:29PM
(Morningstar Research) +5.95%
01:19PM
10:50AM
10:35AM
(Thomson Reuters StreetEvents)
09:53AM
08:10AM
07:59AM
(Investor's Business Daily)
Jan-30-24 11:06PM
06:30PM
05:15PM
04:45PM
04:44PM
04:28PM
(Associated Press Finance)
04:05PM
Jan-29-24 08:22AM
07:30AM
02:53AM
Jan-25-24 10:50PM
09:15AM
Jan-24-24 11:25AM
Jan-22-24 05:16AM
05:00AM
Jan-18-24 08:50AM
Jan-17-24 08:00AM
Jan-15-24 10:03AM
Jan-12-24 03:49PM
(Investor's Business Daily)
01:55PM
Jan-10-24 08:35AM
Jan-08-24 07:20PM
08:00AM
Jan-05-24 08:00AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Boehnlein Glenn S VP, Chief Financial Officer May 15 '24 Sale 327.65 10,000 3,276,516 15,012 May 16 04:16 PM Stiles Spencer S Group President Mar 21 '24 Option Exercise 0.00 203 0 55,602 Mar 25 07:21 PM Pierce James Andrew Group President Mar 21 '24 Option Exercise 0.00 203 0 60,664 Mar 25 07:16 PM Menon Viju Group President Mar 21 '24 Option Exercise 0.00 158 0 13,762 Mar 25 07:11 PM Lobo Kevin Chair and CEO Mar 21 '24 Option Exercise 0.00 905 0 119,719 Mar 25 06:58 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 '24 Option Exercise 0.00 120 0 13,143 Mar 25 06:54 PM Fink M Kathryn VP, Chief HR Officer Mar 21 '24 Option Exercise 0.00 83 0 13,710 Mar 25 06:50 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 '24 Option Exercise 0.00 256 0 31,152 Mar 25 06:45 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 '24 Option Exercise 0.00 36 0 29,898 Mar 25 06:37 PM Berry William E Jr VP, Chief Accounting Officer Mar 08 '24 Option Exercise 154.14 1,480 228,127 5,155 Mar 11 05:55 PM Berry William E Jr VP, Chief Accounting Officer Mar 07 '24 Option Exercise 108.30 17,660 1,912,588 21,335 Mar 11 05:55 PM Berry William E Jr VP, Chief Accounting Officer Mar 07 '24 Sale 358.48 7,690 2,756,730 3,675 Mar 11 05:55 PM Boehnlein Glenn S VP, Chief Financial Officer Feb 09 '24 Sale 342.81 9,600 3,290,952 20,194 Feb 12 04:09 PM STRYKER RONDA E Director Feb 06 '24 Sale 339.95 92,296 31,376,021 3,662,832 Feb 07 05:33 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 05 '24 Option Exercise 93.06 8,060 750,064 33,129 Feb 07 05:00 PM STRYKER RONDA E Director Feb 05 '24 Sale 342.90 201,146 68,973,360 3,755,128 Feb 07 05:33 PM Golston Allan C. Director Feb 02 '24 Option Exercise 96.64 4,570 441,645 18,812 Feb 06 05:24 PM STRYKER RONDA E Director Feb 02 '24 Option Exercise 81.14 4,355 353,365 7,642 Feb 06 05:16 PM Golston Allan C. Director Feb 02 '24 Sale 341.00 3,273 1,116,093 14,242 Feb 06 05:24 PM Pierce James Andrew Group President Jan 16 '24 Option Exercise 81.14 10,230 830,062 57,999 Jan 16 04:23 PM Boehnlein Glenn S VP, Chief Financial Officer Jan 11 '24 Option Exercise 95.99 60,005 5,760,022 68,981 Jan 16 04:16 PM Silvernail Andrew K Director Dec 05 '23 Option Exercise 81.14 4,355 353,365 11,472 Dec 07 04:57 PM Datar Srikant M. Director Dec 04 '23 Option Exercise 93.06 1,795 167,043 5,611 Dec 05 04:25 PM Datar Srikant M. Director Dec 01 '23 Sale 298.22 500 149,112 3,816 Dec 05 04:25 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 28 '23 Option Exercise 81.14 8,875 720,118 30,806 Nov 28 08:16 PM Berry William E Jr VP, Chief Accounting Officer Nov 28 '23 Sale 292.28 573 167,477 2,909 Nov 28 08:09 PM Boehnlein Glenn S VP, Chief Financial Officer Nov 27 '23 Option Exercise 81.14 11,955 970,029 16,570 Nov 28 08:02 PM Lobo Kevin Chair and CEO Nov 17 '23 Option Exercise 81.14 160,215 12,999,845 241,249 Nov 21 05:18 PM Stiles Spencer S Group President Nov 17 '23 Option Exercise 81.14 11,090 899,843 53,732 Nov 21 04:33 PM Lobo Kevin Chair and CEO Nov 17 '23 Sale 287.91 56,483 16,261,812 81,034 Nov 21 05:18 PM Datar Srikant M. Director Nov 16 '23 Sale 291.92 500 145,962 4,316 Nov 16 05:56 PM Datar Srikant M. Director Nov 15 '23 Sale 287.50 500 143,751 4,816 Nov 16 05:56 PM Datar Srikant M. Director Nov 14 '23 Sale 287.57 750 215,681 5,316 Nov 16 05:56 PM Menon Viju Group President Sep 06 '23 Sale 289.00 5,000 1,445,000 6,994 Sep 08 04:20 PM Datar Srikant M. Director Aug 10 '23 Sale 286.23 750 214,671 6,066 Aug 10 04:24 PM Datar Srikant M. Director Aug 08 '23 Option Exercise 93.06 2,000 186,120 7,467 Aug 10 04:24 PM Datar Srikant M. Director Jun 01 '23 Sale 278.50 500 139,250 5,467 Jun 05 05:24 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite